Vivalink Introduces New Adhesive for Wearable ECG

Vivalink has released its new wearable ECG sensor adhesive that improves the detection of p-waves during ambulatory cardiac monitoring. P-wave abnormalities can predict future adverse cardiac events, including atrial fibrillation, ischemic stroke, and even sudden cardiac death.

As a newly introduced companion to Vivalink’s rechargeable, re-usable multi-vital ECG patch, the adhesive is being touted as a critical enhancement to Vivalink’s wearable monitors, supporting earlier intervention, improved patient outcomes, and high-quality data collection in clinical trials.

Key features of the upgraded adhesive include:

• Modified Lead 1 placement to enhance p-wave visibility
• Single use, seven-day wear time with water resistance
• Contoured design for maximum flexibility of movement
• Optimized for both comfort and data integrity
• Validated for use in remote and in-person clinical trial settings

Worn vertically on the center chest above the sternum, the adhesive increases p-wave signal detection by up to 160%. P-waves represent the electrical activity within the heart’s upper chambers and are important atrial health markers. Subtle changes in their shape or size can be early indicators of atrial disease, making clear signal capture vital for clinical decision-making in arrhythmias and atrial fibrillation risk, and strengthens trial data reliability. The adhesive’s design leverages VivaLink’s patented eSkin technology for user comfort and flexibility. It is the latest member of the adhesives family that can be attached to Vivalink’s multi-vital ECG patch.

Vivalink’s multi-vital ECG patch is a lightweight, wearable cardiac monitor built for continuous ECG monitoring in clinical care, remote patient monitoring and clinical research environments. Reusable and chargeable, the patch streams live ECG and vital signs such as heart rate, respiratory rate, and skin temperature while also storing data locally to prevent gaps due to a network disruption. With up to two weeks of use between charges and a comfortable design, the patch allows for long-term monitoring without disrupting patients’ daily activities.

“Continual innovation in wearable monitoring technology is at the core of our mission,” Vivalink CEO Jiang Li said. “By improving p-wave signal clarity, this new adhesive advances the accuracy and reliability of cardiac monitoring. The result is better support for clinicians in identifying arrhythmias early, while easing the burden on patients through comfortable, long-term use in ambulatory settings, hospital-at-home programs and clinical trials that demand accurate ECG data.”

Vivalink provides digital healthcare solutions for remote patient monitoring in healthcare and clinical trials. By combining medical wearables, advanced algorithms, and clinical applications, the firm strives to provide a more effective and accessible approach to patient care.